金陵药业(000919) - 2018 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders was ¥29,895,337.43, a decrease of 29.65% year-on-year[8]. - Operating revenue for the reporting period was ¥741,845,556.24, down 1.78% compared to the same period last year[8]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥28,497,233.96, an increase of 7.27% year-on-year[8]. - Basic earnings per share were ¥0.0593, a decrease of 29.66% compared to the same period last year[8]. - The weighted average return on net assets was 1.19%, down 0.50% year-on-year[8]. - Cash flow from operating activities for the year-to-date was ¥336,547,899.90, an increase of 25.48%[8]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,589[12]. - The largest shareholder, Nanjing New Industry Investment Group Co., Ltd., held 45.23% of the shares[12]. Asset Changes - Total assets at the end of the reporting period reached ¥3,900,525,587.54, an increase of 1.13% compared to the end of the previous year[8]. - Prepayments at the end of the reporting period increased by 188.35% compared to the beginning of the year, mainly due to the company's procurement business adopting a prepayment method[16]. - Other receivables at the end of the reporting period rose by 91.23% compared to the beginning of the year, primarily due to an increase in the scope of consolidation[16]. - Other current assets increased by 55.97% at the end of the reporting period compared to the beginning of the year, mainly due to an increase in short-term bank wealth management products purchased by subsidiaries[16]. - Intangible assets at the end of the reporting period increased by 30.65% compared to the beginning of the year, mainly due to an increase in the scope of consolidation[16]. - Goodwill at the end of the reporting period increased by 101.13% compared to the beginning of the year, primarily due to the acquisition of 65% equity in Huzhou Social Welfare Center Development Co., Ltd.[16]. Income and Expenses - Financial expenses decreased by 107.03% compared to the same period last year, mainly due to a reduction in interest expenses[17]. - Other income increased by 107.69% compared to the same period last year, primarily due to an increase in subsidy income[17]. - Non-operating income increased by 277.54% compared to the same period last year, mainly due to increased compensation income from the subsidiary Suqian People's Hospital[18]. Cash Flow - Net cash flow from investing activities decreased by 170.51% compared to the same period last year, mainly due to a smaller decline in cash outflows from investment activities compared to cash inflows[18]. - Net cash flow from financing activities decreased by 990.28% compared to the same period last year, primarily due to a reduction in cash received from borrowings[20]. Securities and Investments - The fair value of securities held at the end of the period was 8,889 million, with a loss of 273.99 million during the reporting period[26]. - The company reported a fair value loss of 1,312 million for the securities held, with a total of 6,690 million at the end of the period[26]. - The company has a total of 3,976 million in other securities investments, with a loss of 457.9 million during the reporting period[27]. - The annualized return on entrusted financial products was 5.10%, with a total investment of 24,000 million[29]. - The company reported a fair value loss of 935.5 million for Shanghai Petrochemical, with a total of 6,446 million at the end of the period[26]. - The total amount of securities investments approved by the board was 66,757 million, with a loss of 2,297 million during the reporting period[27]. - The company has a total of 1,950 million in other securities investments, with a fair value gain of 21,536 million[27]. - The company reported a fair value loss of 180.2 million for Zhongtian Technology, with a total of 1,202 million at the end of the period[27]. - The company has a total of 5,000 million in entrusted financial management, with a fair value gain of 35,881 million[29]. - The company reported a total of 38,000 in financial products with a return rate of 5.00%[31]. - The company has no derivative investments during the reporting period[32]. Compliance and Communication - The company conducted multiple phone communications regarding its operational status on September 6, 11, and 19, 2018[33]. - There were no instances of non-compliance with external guarantees during the reporting period[34]. - The company did not experience any non-operational fund occupation by controlling shareholders or related parties[35].